Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

NCT04851015 is registered in ClinicalTrials.gov with Todd C. Lee MD MPH FIDSA as lead sponsor.

NCT NCT04851015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04851015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
Lead sponsor
Todd C. Lee MD MPH FIDSA
Phase
Phase 3
Overall status
Recruiting
Start date
November 28, 2025
Completion date
December 31, 2030
Enrollment
416 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumocystis, pneumocystis carinii infection, pneumocystis carinii; infection, resulting from hiv disease, pneumocystis infections, pneumocystis jirovecii infection, pneumocystis pneumonia, pneumocystosis associated with aids, pneumocystosis; pneumonia (etiology)